Waltham, Massachusetts-based Eloxx Pharmaceuticals has hired Neil Belloff as executive vice president, general counsel and corporate secretary. He is the company’s first general counsel.
Belloff joins Eloxx from Celgene Corporation, where he has served as senior corporate counsel since 2011. According to his new firm, he has more than 30 years of legal and business experience, with management and project development responsibilities in areas including corporate governance, compliance, risk assessment, strategic planning, regulatory compliance, M&A, capital formation, privacy, pharmaceutical development and securities matters.
Eloxx is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat cystic fibrosis, cystinosis and other diseases caused by mutations limiting production of functional proteins.
Earlier in his career, Belloff was executive vice president and US corporate and securities counsel at Deutsche Telecom, and also worked with various New York-based law firms and as a senior attorney-adviser in the SEC’s division of corporation finance.
‘We are extremely pleased to have attracted someone with Neil’s extensive legal, business and transactional experience to our leadership team,’ Eloxx chair and CEO Robert Ward says in a statement. ‘I believe Neil’s experience advising public companies through the full development life-cycle and his knowledge of the global biopharmaceutical industry, as well as his expertise in corporate governance and compliance, will add significant value to the company as it matures.’
Ben Maiden
Ben Maiden is the editor-at-large of Governance Intelligence, an IR Media publication, having joined the company in December 2016. He is based in New York. Ben was previously managing editor of Compliance Reporter, covering regulatory and compliance...
